z-logo
open-access-imgOpen Access
Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure
Author(s) -
Charles Steenbergen,
Cynthia A. Afshari,
John G. Petranka,
Jennifer B. Collins,
Karla Martin,
Lee Bennett,
Astrid C. Haugen,
Pierre R. Bushel,
Elizabeth Murphy
Publication year - 2003
Publication title -
ajp heart and circulatory physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.524
H-Index - 197
eISSN - 1522-1539
pISSN - 0363-6135
DOI - 10.1152/ajpheart.00707.2002
Subject(s) - heart failure , dilated cardiomyopathy , apoptosis , pathogenesis , biology , signal transduction , gene expression profiling , gene expression , cardiomyopathy , phosphorylation , muscle hypertrophy , gene , heart disease , medicine , cancer research , microbiology and biotechnology , endocrinology , immunology , genetics
Dilated cardiomyopathy, a disease of unknown etiology and pathogenesis, is associated with heart failure and compensatory hypertrophy. Although cell and animal models suggest a role for altered gene expression in the transition to heart failure, there is a paucity of data derived from the study of human heart tissue. In this study, we used DNA microarray profiling to investigate changes in the expression of genes involved in apoptosis that occur in human idiopathic dilated cardiomyopathic hearts that had progressed to heart failure. We observed altered gene expression consistent with a proapoptotic shift in the TNF-alpha signaling pathway. Specifically, we found decreased expression of TNF-alpha- and NF-kappaB-induced antiapoptotic genes such as growth arrest and DNA damage-inducible (GADD)45beta, Flice inhibitory protein (FLIP), and TNF-induced protein 3 (A20). Consistent with a role for apoptosis in heart failure, we also observed a significant decrease in phosphorylation of BAD at Ser-112. This study identifies several pathways that are altered in human heart failure and provides new targets for therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom